NIH alternative medicine advisory council proposes creation of FDA relations working group.
This article was originally published in The Tan Sheet
Executive Summary
NIH OFFICE OF COMPLEMENTARY & ALTERNATIVE MEDICINE WORKING GROUP ON FDA RELATIONS proposed during a Sept. 16-17 meeting of the Alternative Medicine Program Advisory Council (AMPAC) in Bethesda, Md. During the meeting, the council discussed the merits of creating a working group that would draft a letter to "address the perception of over-aggressive enforcement tactics by FDA against alternative practitioners."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning